Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

DDX3 is an RNA helicase with oncogenic properties. The small molecule inhibitor RK-33 is designed to fit into the ATP binding cleft of DDX3 and hereby block its activity. RK-33 has shown potent activity in preclinical cancer models. However, the mechanism behind the antineoplastic activity of RK-33...

Descripción completa

Detalles Bibliográficos
Autores principales: Heerma van Voss, Marise R., Kammers, Kai, Vesuna, Farhad, Brilliant, Justin, Bergman, Yehudit, Tantravedi, Saritha, Wu, Xinyan, Cole, Robert N., Holland, Andrew, van Diest, Paul J., Raman, Venu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050443/
https://www.ncbi.nlm.nih.gov/pubmed/29684792
http://dx.doi.org/10.1016/j.tranon.2018.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050443/
https://www.ncbi.nlm.nih.gov/pubmed/29684792
http://dx.doi.org/10.1016/j.tranon.2018.04.001

Ejemplares similares